# Stage I Multiple Myeloma Treatment

> **NCT00733538** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 89 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** zometa

## Key facts

- **NCT ID:** NCT00733538
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2009-11
- **Final completion:** 2012-11
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00733538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00733538, "Stage I Multiple Myeloma Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00733538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
